Fig. 3From: Antiretroviral therapy and liver disease progression in HIV and hepatitis C co-infected patients: a systematic review and meta-analysisUnadjusted relative risk of liver-related mortality in HIV/HCV co-infected patients receiving cART versus no cARTBack to article page